PSLCX
Price
$12.04
Change
+$0.03 (+0.25%)
Updated
Jun 23 closing price
Net Assets
312.94M
SSGSX
Price
$52.52
Change
-$0.29 (-0.55%)
Updated
Jun 23 closing price
Net Assets
4.67B
Interact to see
Advertisement

PSLCX vs SSGSX

PSLCX vs SSGSX Comparison Chart in %
View a ticker or compare two or three
VS
PSLCX vs. SSGSX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PSLCX is a Buy and SSGSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SSGSX has more cash in the bank: 4.67B vs. PSLCX (313M). PSLCX pays higher dividends than SSGSX: PSLCX (1.02) vs SSGSX (0.54). PSLCX was incepted earlier than SSGSX: PSLCX (27 years) vs SSGSX (27 years). PSLCX (1.89) is less costly to investors than SSGSX (1.23). PSLCX is a more actively managed with annual turnover of: 100.00 vs. SSGSX (50.00). PSLCX has a lower initial minimum investment than SSGSX: PSLCX (500) vs SSGSX (2500). SSGSX annual gain was more profitable for investors over the last year : 23.02 vs. PSLCX (20.37). PSLCX return over 5 years is better than : 8.18 vs. SSGSX (-3.49).
PSLCXSSGSXPSLCX / SSGSX
Total Expense Ratio1.891.23154%
Annual Report Gross Expense Ratio1.891.23154%
Fund Existence27 years27 years-
Gain YTD18.91118.170104%
Front LoadN/A6%-
Min. Initial Investment500250020%
Min. Initial Investment IRAN/AN/A-
Net Assets313M4.67B7%
Annual Yield % from dividends1.020.54189%
Returns for 1 year20.3723.0289%
Returns for 3 years34.8717.95194%
Returns for 5 years8.18-3.49-235%
Returns for 10 years8.6048.5318%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ELVN48.552.59
+5.64%
Enliven Therapeutics
SXC8.37N/A
N/A
Suncoke Energy
GNLX2.92N/A
N/A
Genelux Corp
AFRM71.83-0.37
-0.51%
Affirm Holdings
NCNA1.72-0.11
-6.01%
NuCana plc